Targeted Oncology

Treating Together

Health EN ↓ 102 episodes

Targeted Oncology brings you Treating Together , a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Be sure to visit the podcast's website and support the creator: www.targetedonc.com

Author

Targeted Oncology

Category

Health

Podcast website

www.targetedonc.com

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding 01.04.2024

In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States. 

S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC 15.03.2024

In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20 insertion mutation-positive non-small cell lung cancer.

S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC 01.03.2024

In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy. 

S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing 15.02.2024

In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.

S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC 01.02.2024

In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.

S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer 15.01.2024

In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina Health, delves into the critical topic of prostate cancer screening, particularly for men within a community setting, and discusses some of the recent advancements in the prostate cancer space.

S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care 15.12.2023

In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.

S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities 30.11.2023

In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to discuss his interest and research in immunotherapy toxicities. 

S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC 15.11.2023

In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.

S4 Ep17: Bridging Science and Compassion in Cancer Care 31.10.2023

In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego (UCSD) Medical Center, UCSD Health, to discuss insights into her passion for oncology and some of the experiences that have helped to shape her career.

S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer 13.10.2023

In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.

S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field 29.09.2023

In our first episode of Emerging Experts, Aakash Desai, MD, MPH, discusses his journey through the oncology field by reminiscing on the encouraging guidance of his mentors, personal research goals, and his experiences thus far as an oncologist.

S4 Ep14: First Real-World Data on Second-Generation AR Inhibitor Use in nmCRPC 18.09.2023

Alicia Morgan, MD, MPH on real-world data from the DEAR study.

S4 Ep13: Strategies for Neoadjuvant NSCLC Treatment 01.09.2023

An interview with Benny Weskler, MBA, MD, FACS, FACCP of Allegheny Health Network.

S4 Ep12: Lessons from Real-World Cases of Small Cell Lung Cancer 15.08.2023

Federico Albrecht, MD discusses 2 small cell lung cancer cases.

S4 Ep11: Social Determinants of Health Impacting Oncology Today 31.07.2023
S4 Ep10: Recommendations for Treating Central Nervous Systems Cancers 14.07.2023

Craig Horbinski, MD, PhD, unpacks the NCCN Clinical Practice Guidelines for central nervous system tumors.

S4 Ep9: Mitigating Cardiotoxicity Resulting from Immune Checkpoint Inhibitor Therapy 30.06.2023

In season 4, episode 9 of Targeted Talks, Kerry Reynolds, MD of Massachusetts General Hospital discusses the occurrence of myocarditis in patients with cancer treated with immune checkpoint inhibitors.

S4 Ep8: Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer 23.06.2023

An interview with Ruchi Garg, MD of City of Hope.

S4 Ep7: Exciting Activity in Chronic Lymphocytic Leukemia 31.05.2023
S4 Ep6: Anticipating Novel Treatments for the RAI-Refractory DTC Armamentarium 15.05.2023

An interview with Warren Swegal, MD.

S4 Ep5: Advancing the Treatment of Alveolar Soft Part Sarcoma 26.04.2023

An interview with Alice P. Chen, MD of the National Cancer Institute.

S4 Ep4: Understanding and Treating Mucosal Melanoma 14.04.2023

Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.

S4 Ep3: Hitting New Targets in Metastatic Prostate Cancer 16.03.2023

In season 4, episode 3 of Targeted Talks, Pedro Barata, MD, MSc, discusses the present and future of prostate cancer precision medicine.

S4 Ep2: The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment 28.02.2023

A talk with Sara A. Hurvitz, MD about advances in the HER2-positive breast cancer space.

Listen to the Treating Together podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.